EP 1796637 A4 20100113 - TARGETED DELIVERY OF LIDOCAINE AND OTHER LOCAL ANESTHETICS AND A METHOD FOR TREATMENT OF COUGH AND TUSSIVE ATTACKS
Title (en)
TARGETED DELIVERY OF LIDOCAINE AND OTHER LOCAL ANESTHETICS AND A METHOD FOR TREATMENT OF COUGH AND TUSSIVE ATTACKS
Title (de)
GEZIELTE ABGABE VON LIDOCAIN UND ANDEREN LOKALANÄSTHETIKA UND VERFAHREN ZUR BEHANDLUNG VON HUSTEN UND TUSSIVEN ANFÄLLEN
Title (fr)
DISTRIBUTION CIBLEE DE LIDOCAINE ET AUTRES ANESTHÉSIQUES LOCAUX ET PROCEDE DE TRAITEMENT DE LA TOUX ET DES ATTAQUES LARYNGEES
Publication
Application
Priority
- US 2005002555 W 20050128
- US 61165604 P 20040920
- US 63502204 P 20041209
Abstract (en)
[origin: US2006062739A1] An inhalable lidocaine solution for treatment of asthma and a method for treatment of asthma with the reduced need for concurrent administration of oral corticosteroids in asthmatic patients. The lidocaine solution or lidocaine dry powder is delivered by an electronic nebulizer or by dry powder inhaler or dose meter one to several times a day.
IPC 8 full level
A61K 9/12 (2006.01); A61K 9/14 (2006.01); A61K 31/24 (2006.01); A61K 31/47 (2006.01)
CPC (source: EP US)
A61K 9/0075 (2013.01 - EP US); A61K 9/0078 (2013.01 - EP US); A61K 9/008 (2013.01 - EP US); A61K 31/24 (2013.01 - EP US); A61K 31/445 (2013.01 - EP US); A61K 31/47 (2013.01 - EP US); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 11/08 (2017.12 - EP); A61P 11/14 (2017.12 - EP); A61P 23/00 (2017.12 - EP); A61P 23/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61K 9/08 (2013.01 - EP US)
Citation (search report)
- [XY] US 2003171402 A1 20030911 - GLEICH GERALD J [US], et al
- [XY] DECCO M L ET AL: "Nebulized lidocaine in the treatment of severe asthma in children: a pilot study", ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ARLINGTON HEIGHTS, IL, US, vol. 82, no. 1, 1 January 1999 (1999-01-01), pages 29 - 32, XP009126326, ISSN: 1081-1206
- [XY] HUNT L W ET AL: "EFFECT OF NEBULIZED LIDOCAINE ON SEVERE GLUCOCORTICOID-DEPENDENT ASTHMA", MAYO CLINIC PROCEEDINGS, MAYO MEDICAL VENTURES, ROCHESTER, MN, vol. 71, no. 4, 1 April 1996 (1996-04-01), pages 361 - 368, XP002069072, ISSN: 0025-6196
- [Y] PARI AEROSOL RESEARCH INSTITUTE: "PARI's eFlow(R), an Electronic Aerosol Device for Medication Delivery, Receives FDA 510(k) Market Clearance", 18 April 2004 (2004-04-18), Monterey, California, USA, pages 1 - 2, XP002558312, Retrieved from the Internet <URL:http://www2.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-18-2004/0002176356&EDATE> [retrieved on 20091201]
- See references of WO 2006036180A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2006062739 A1 20060323; AU 2005290312 A1 20060406; CA 2581209 A1 20060406; EP 1796637 A1 20070620; EP 1796637 A4 20100113; JP 2008513444 A 20080501; JP 2008513445 A 20080501; NO 20071654 L 20070619; NO 20071655 L 20070619; WO 2006036180 A1 20060406; WO 2006036181 A1 20060406
DOCDB simple family (application)
US 4616405 A 20050128; AU 2005290312 A 20050128; CA 2581209 A 20050128; EP 05712137 A 20050128; JP 2007532307 A 20050128; JP 2007532308 A 20050128; NO 20071654 A 20070329; NO 20071655 A 20070329; US 2005002555 W 20050128; US 2005003327 W 20050128